Vnitr Lek 2012, 58(4):261-262

Význam biomarkerů NGAL a cystatin C u kardiovaskulárních onemocnění - editorial

F. Málek
Kardiovaskulární centrum Nemocnice Na Homolce Praha, přednosta prim. MUDr. Štěpán Černý, CSc.

Received: November 16, 2011; Published: April 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Málek F. Význam biomarkerů NGAL a cystatin C u kardiovaskulárních onemocnění - editorial. Vnitr Lek. 2012;58(4):261-262.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Helánová K, Pařenica J, Dlouhý V et al. Význam biomarkerů NGAL a cystatinu C u kardiovaskulárních onemocnění. Vnitř Lék 2012; 58: 286-290. Go to PubMed...
    2. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008; 358: 2148-2159. Go to original source... Go to PubMed...
    3. Bettencourt P, Azevedo A, Pimenta J et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004; 110: 216-2174. Go to original source... Go to PubMed...
    4. Pfisterer M, Buser P, Riskli H et al. TIME-CHF Investigators. BNP-Guided vs Symptom-Guided Heart Failure Therapy: The Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) Randomized Trial. JAMA 2009; 301: 383-392. Go to original source... Go to PubMed...
    5. Weinberg EO, Shimpo M, Hurwitz S et al. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 2003; 107: 721-726. Go to original source... Go to PubMed...
    6. Pousset F, Mason F, Chavirovskaia O et al. Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur Heart J 2000; 21: 1009-1014. Go to original source... Go to PubMed...
    7. Neuhold S, Huelsman M, Strunk G et al. Comparison of Copeptin, B-Type Natriuretic Peptide, and Amino-Terminal Pro-B-Type Natriuretic Peptide in Patiens With Chronic Heart Failure: Prediction of Death at Different Stages of the Disease. J Am Coll Cardiol 2008; 52: 266-272. Go to original source... Go to PubMed...
    8. de Boer RA, Voors AA, Muntendam P et al. Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail 2009; 11: 811-817. Go to original source... Go to PubMed...
    9. Lassus J, Harjola VP, Sund R et al. FINN-AKVA Study group. Prognostic valuse of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J 2007; 28: 1841-1847. Go to original source... Go to PubMed...
    10. Shrestha KL, Troughton RW, Borowski AG et al. Relation of plasma neutrophil gelatinase-associated lipocalin (NGAL) levels with myocardial function and prognosis in patients with chronic systolic heart failure. JACC 2010; 55: A36. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.